In summary, our study demonstrated that anemoside B4 exhibited significant protective effects on TNBS-induced colitis via suppressing the S100A9/MAPK/NF-κB signaling pathway and inhibited neutrophil recruitment and activation (Fig. 7). The gene discussed is S100A9; the disease is colitis.